Selkoe to discuss #amyloid and #Alzheimer’s in wake of another disappointing drug study

A recent story in The Atlantic asks "Is the Leading Theory About Alzheimer's Wrong?" For years, scientist have been arguing about whether amyloid protein in the brain is a cause,or just a symptom of condition.  Pharma has been confident -- or desperate -- enough in the science to bet on amyloid clearing drugs, but they … Continue reading Selkoe to discuss #amyloid and #Alzheimer’s in wake of another disappointing drug study

STAT, The Boston Globes’s national health and science website, tosses us a story

We don't know if the copy is going to be in the paper or just online, but today, STAT makes its debut -- in both formats. The site promises "Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. … Continue reading STAT, The Boston Globes’s national health and science website, tosses us a story

Is Avandia safe? FDA to consider restrictions on the diabetes drug, local docs in the fray

Dr. Clifford J. Rosen, director of clinical and translational medicine at the Maine Medical Center in Portland,  led the advisory committee that on 2010 set strict limits on the use of the  diabetes drug Avandia after it was linked to  heart problems. The New York Times reported on Sunday on the FDA's  meeting this week, where … Continue reading Is Avandia safe? FDA to consider restrictions on the diabetes drug, local docs in the fray

Undoing: BU aging study, MA disclosure laws

The take-down of the BU study began Wednesday and continues. More here on Nature Network Boston. Also, the Mass House of Representatives voted to repeal the state's disclosure law, which requires drug makers to report donation to researchers. From AP via the Globe: House leaders defended the vote to repeal the ban, approved just two … Continue reading Undoing: BU aging study, MA disclosure laws

New info lets patients, researchers compare quality at hospitals nationwide

Check out your own hospital or compare it to others. The updated information on Hospital Compare includes data on the rates of outpatient MRIs for low back pain, outpatient re-tests after a screening mammogram, as well as two ratios that explain how frequently outpatient departments gave patients "double" computed tomography (CT) scans when a single scan … Continue reading New info lets patients, researchers compare quality at hospitals nationwide

The NYTimes and the Dartmouth Atlas

The Science Journalism Tracker, from the Knight science writing program at MIT, offers helpful analysis. Yesterday, it took on a New York Times story on the Dartmouth Atlas. The Times report cited take-downs of the program's mapping of health care costs and practice pattern variations.    The maps “appeared to show where the waste in the system could … Continue reading The NYTimes and the Dartmouth Atlas

Screen baby, screen — News coverage of new mammography guidelines

 BHN is a big fan of the health news blog produced by fellow health writer/journalism prof Gary Schwitzer at the University of Minnesota. And while we hate gratuitous attacks on the so-called "lamestream" media, there is a lot of really, really bad health reporting out there. Schwitzer follows and rates the coverage and he is always spot on. So, check out his comments … Continue reading Screen baby, screen — News coverage of new mammography guidelines

Lilly funds 60 Boston docs

From The Boston Globe: At least 60 Massachusetts doctors collectively have earned more than a half-million dollars this year as speakers paid by pharmaceutical giant Eli Lilly & Co. - including two Boston Medical Center physicians whose participation is being reviewed for possible violation of a hospital policy against marketing activities by its doctors. After … Continue reading Lilly funds 60 Boston docs

Senate hearing: Industry support for medical education

Lots of locals at Thursday's Senate hearing on health care industry support for continuing medical education (CME) for doctors. Click here for the video. From the U.S. Senate Special Committee on Aging web site. Dr. Eric Campbell, Associate Professor at Harvard University, discussed the Institute of Medicine’s (IoM) recent study on conflict of interest in medical research, … Continue reading Senate hearing: Industry support for medical education

BHN exclusive: Relman on ACRE conflict of interest meeting

During his 14 years as editor of the New England Journal of Medicine – most of the 80’s and some change – Dr. Arnold S. Relman often commented on the influence of money on medicine. He still doesn’t like it. BHN noticed him at last week’s meeting of Association of Clinical Researchers and Educators (ACRE) … Continue reading BHN exclusive: Relman on ACRE conflict of interest meeting